NEW YORK (GenomeWeb News) – Biogen Idec will use Almac Diagnostics’ expertise in extracting genetic information from formalin-fixed paraffin embedded tissue, Almac said yesterday.
 
Craigavon, Northern Ireland-based Almac said that Biogen Idec would use the process for SNP analysis in a phase II study of a drug for treating gastrointestinal stromal tumors. The firm’s process enables researchers to use FFPE samples in qPCR and microarray SNP genotyping and gene expression studies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.